| # | Drug | Count |
|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 56 |
| 1 | EPOPROSTENOL | 31 |
| 2 | TREPROSTINIL | 30 |
| 3 | AMBRISENTAN | 26 |
| 4 | FUROSEMIDE | 26 |
| 5 | OMEPRAZOLE MAGNESIUM | 20 |
| 6 | SILDENAFIL CITRATE | 20 |
| 7 | TADALAFIL | 20 |
| 8 | GABAPENTIN | 17 |
| 9 | OMEPRAZOLE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 56 | 0.0064 |
| 1 | CARBAMIDE PEROXIDE | 2 | 0.0045 |
| 2 | NIZATIDINE | 5 | 0.0033 |
| 3 | EPOPROSTENOL | 31 | 0.0024 |
| 4 | PRUCALOPRIDE | 2 | 0.0008 |
| 5 | CODEINE SULFATE | 2 | 0.0006 |
| 6 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 7 | ENTACAPONE | 2 | 0.0005 |
| 8 | MIDODRINE HYDROCHLORIDE | 2 | 0.0004 |
| 9 | AMANTADINE HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 57 |
| 1 | Endothelin Receptor Antagonist [EPC] | 37 |
| 2 | Corticosteroid [EPC] | 35 |
| 3 | Loop Diuretic [EPC] | 27 |
| 4 | Proton Pump Inhibitor [EPC] | 27 |
| 5 | Factor Xa Inhibitor [EPC] | 25 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 25 |
| 7 | Platinum-based Drug [EPC] | 24 |
| 8 | Osmotic Laxative [EPC] | 23 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 5 | Prostacycline Vasodilator [EPC] | 57 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | Influenza A M2 Protein Inhibitor [EPC] | 5 | 0.0003 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |